Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma
PDF | HTML | How to cite
Metrics: PDF 1440 views | HTML 1933 views | ?
Imran Nawaz1,2*, Li-Fu Hu1,#, Zi-Ming Du1,3*, Khalid Moumad4,5, Ilya Ignatyev1*, Tatiana V. Pavlova1, Vladimir Kashuba1, Malin Almgren6,7, Eugene R. Zabarovsky1,8†, Ingemar Ernberg1,#
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
2Department of Microbiology, Faculty of Life Sciences, University of Balochistan, Quetta, Pakistan
3State Key Laboratory of Oncology in South China, and Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, P.R. China
4Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
5Oncovirology Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco
6Department Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
7Centre for Molecular Medicine, Stockholm, Sweden
8Department of Clinical & Experimental Medicine, Division of Cell Biology, Linköping University, Linköping, Sweden
*These authors have contributed equally to this work
#These senior authors have contributed equally to this work
Ingemar Ernberg, e-mail: [email protected]
Li-Fu Hu, e-mail: [email protected]
Keywords: nasopharyngeal carcinoma, ITGA9, DNA methylation, notI microarrays, epigenetics
Received: March 15, 2015 Accepted: August 27, 2015 Published: September 08, 2015
Epigenetic silencing of tumor suppressor genes (TSGs) by promoter methylation can be an early event in the multi-step process of carcinogenesis. Human chromosome 3 contains clusters of TSGs involved in many cancer types including nasopharyngeal carcinoma (NPC), the most common cancer in Southern China. Among ten candidate TSGs identified in chromosome 3 using NotI microarray, ITGA9 and WNT7A could be validated. 5′-aza-2′ deoxycytidine treatment restored the expression of ITGA9 and WNT7A in two NPC cell lines. Immunostaining showed strong expression of these genes in the membrane and cytoplasm of adjacent control nasopharyngeal epithelium cells, while they were weakly expressed in NPC tumor cells. The ITGA9 promoter showed marked differentially methylation between tumor and control tissue, whereas no differentially methylation could be detected for the WNT7A promoter. The expression level of ITGA9 in NPC tumors was downregulated 4.9-fold, compared to the expression in control. ITGA9 methylation was detected by methylation specific PCR (MSP) in 56% of EBV positive NPC-cases with 100% specificity. Taken together, this suggests that ITGA9 might be a TSG in NPC that is involved in tumor cell biology. The possibility of using ITGA9 methylation as a marker for early detection of NPC should further be explored.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.